Two syntheses of FF-MAS

Organic Letters

Volumn 5, Issue 11, 2003, Pages 1837-1839

  Blume, Thorsten ^a   Guttzeit, Marc ^a   Kuhnke, Joachim ^a   Zorn, Ludwig ^a  

^a BAYER PHARMA AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4,4 DIMETHYL 5ALPHA CHOLESTA 8,14,24 TRIEN 3BETA OL; STEROL DERIVATIVE; UNCLASSIFIED DRUG; 4,4 DIMETHYLCHOLESTA 8,14,24 TRIENOL; 4,4-DIMETHYLCHOLESTA-8,14,24-TRIENOL; CHOLESTANE DERIVATIVE; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; ERGOSTEROL; STEROL;

ARTICLE; DEGRADATION; DRUG SYNTHESIS; LIPOGENESIS; CHEMISTRY; FEMALE; HUMAN; MEIOSIS; METABOLISM; OVARY FOLLICLE FLUID; OXIDATION REDUCTION REACTION; SACCHAROMYCES CEREVISIAE; SYNTHESIS;

CHOLESTENES; ERGOSTEROL; FEMALE; FOLLICULAR FLUID; HUMANS; INDICATORS AND REAGENTS; MEIOSIS; OXIDATION-REDUCTION; SACCHAROMYCES CEREVISIAE; STEROLS;

EID: 0041350420     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol0343156     Document Type: Article

References (32)

1. Byskov, A. G.; Andersen, C. Y.; Nordholm, L.; Thogersen, H.; Guoliang, X.; Wassmann, O.; Andersen, J. V.; Guddal, E.; Roed, T. Nature 1995, 374, 559.
2. Baltsen, M.; Byskov, A. G. Biomed. Chromatogr. 1999, 13, 382.
3. (a) Hegele-Hartung, C.; Lessl, M.; Ottesen, J. L.; Grondahl, C. Human Reprod. [Suppl.] 1998, 11, 193.
4. (b) Hegele-Hartung, C.; Lessl, M.; Ottesen, J. L.; Grondahl, C. Human Reprod. [Suppl.] 1998, 13, 98.
5. For recent reviews see: (a) Hegele-Hartung, C.; Blume, T.; Lessl, M.; Ottesen, J. L.; Grondahl, C. Reproduktionsmedizin 2000, 16, 129. (b) Byskov, A. G.; Andersen, C. Y.; Leonardsen, L.; Baltsen, M. J. Exp. Zool. 1999, 285, 237. (c) Byskov, A. G.; Baltsen, M.; Andersen, C. Y. J. Mol. Med. 1998, 76, 818.
6. For recent reviews see: (a) Hegele-Hartung, C.; Blume, T.; Lessl, M.; Ottesen, J. L.; Grondahl, C. Reproduktionsmedizin 2000, 16, 129. (b) Byskov, A. G.; Andersen, C. Y.; Leonardsen, L.; Baltsen, M. J. Exp. Zool. 1999, 285, 237. (c) Byskov, A. G.; Baltsen, M.; Andersen, C. Y. J. Mol. Med. 1998, 76, 818.
7. For recent reviews see: (a) Hegele-Hartung, C.; Blume, T.; Lessl, M.; Ottesen, J. L.; Grondahl, C. Reproduktionsmedizin 2000, 16, 129. (b) Byskov, A. G.; Andersen, C. Y.; Leonardsen, L.; Baltsen, M. J. Exp. Zool. 1999, 285, 237. (c) Byskov, A. G.; Baltsen, M.; Andersen, C. Y. J. Mol. Med. 1998, 76, 818.
8. (a) Downs, S. M.; Ruan, B.; Schroepfer, G. J., Jr. Biol. Reprod. 2001, 64, 80.
9. (b) Vaknin, K. M.; Lazar, S.; Popliker, M.; Tsafriri, A. Biol. Reprod. 2001, 64, 299.
10. (c) Tsafriri, A.; Cao, X.; Vaknin, K. M.; Popliker, M. Mol. Cell. Endocrinol. 2002, 187 (1-2), 197.
11. Grondahl, C.; Hansen, T. H.; Marky-Nielsen, K.; Ottesen, J. L.; Hyttel, P. Human Reprod. 2000, 15 (Suppl. 5, Innovations and Limitations in Assisted Reproduction), 3.
12. Xu, R.; Wilson, W. K.; Matsuda, S. P. T. J. Am. Chem. Soc. 2002, 124, 918.
13. (a) Dolle, R. E.; Schmidt, S. J.; Erhard, K. F.; Kruse., L. I. J. Am. Chem. Soc. 1989, 111, 1, 278.
14. (b) Ruan, B.; Watanabe, S.; Eppig, J. J.; Kwoh, C.; Dzidic, N.; Pang, J. ; Wilson, W. K.; Schroepfer, G. J., Jr. J. Lipid Res. 1998, 39, 2005.
15. (c) Murray, A.; Gronvald, F. C.; Nielsen, J. K.; Faarup, P. Bioorg. Med. Chem. Lett. 2000, 10, 1067.
16. (a) Blume, T.; Esperling, P.; Kuhnke, J. PCT Int. Appl. WO 9952930.
17. (b) Blume, T.; Esperling, P.; Kuhnke, J. Ger. Pat. Appl. DE 19817521, 1999.
18. (c) Geisler, J.; Winter, E. PCT Int. Appl. WO 2000056758.
19. Strategy of this approach (route A) has been disclosed in a German patent application; see ref 9b.
20. Weber, A.; Kenneke, M.; Neef, G. PCT Int. Appl. 92/03465.
21. For a comparable transformation, see: Morisaki, M.; Shibata, M.; Duque, C.; Imamura N.; Ikekawa N. Chem. Pharm. Bull. 1980, 28, 606.
22. Monti, H.; Leandri, G.; Klos-Ringuet, M.; Corriol, C. Synth. Commun. 1983, 13, 1021.
23. Cohen, C. F.; Louloudes, S. J.; Thompson, M. J. Steroids 1967, 9, 591.
24. Analogous side chain isomerization under iodine catalysis has been described: Kircher, H. W.; Rosenstein, F. U. J. Org. Chem. 1987, 52, 2586.
25. Diene isomerizations have been described in the literature: Dolle, R. E. ; Kruse L. I. J. Org. Chem. 1986, 51, 4047 and references therein.
26. Isomeric ratio of Δ24:Δ25 in the side chain is approximately 8:1; the ratio of dienes Δ8,14:Δ6,8(14) is approximately 2.5:1, which corresponds to a content of FF-MAS (Δ8,14,24-triene) of ca. 60%.
27. See ref 8b.
28. Oocyte assay has been adopted from the literature (see ref 1). Naked oocytes (NO) were punctured from ovaries of mice primed with follicle stimulation hormone. After in vitro culture in the presence of 3 mM hypoxanthine and 10 μM of the corresponding test compounds for 15-24 h, germinal vesicle breakdown (GVB) and polarbody (PB) values are measured. The values for GVB and PB are comparable to the data reported in the literature.
29. Commercially available from Research: 10 g costs ca. $300 $.
30. Weber, A.; Kennecke, M.; Mueller, R. Ger. Pat. Appl. DE 2757156, 1979.
31. Johnson, R. L.; Carey, S. C.; Norman, A. W.; Okamura, W. H. J. Med. Chem. 1977, 20, 5.
32. For the synthesis of analogues with enhanced biological activity in the cumulus-enclosed oocyte assay based on route B, see: Blume, T.; Esperling, P.; Hegele-Hartung, C. Eur. Pat. Appl. EP 1245572, 2002.